The Precision Peptide Genetic Test guides whether dual-compound therapy fits your genetic profile
Regulatory status is important in the UK context
Factors such as overall health status, existing medical conditions, and specific weight loss goals are carefully considered during consultation
Akkuzu B, Yilmaz I, Cakmak O, Ozluoglu LN
With its unique ability to stimulate lipolysis and inhibit lipogenesis, AOD-9604 is ideal for those individuals who have discontinued GLP-1 therapy
Fewer Gray-Area Products With compounding expected to decline, consumers will have clearer and more standardized choices, which can reduce confusion about dosing, authenticity, safety and product quality